Technology News

NIH researchers develop AI tool for personalized oncology

April 24, 2024 - On April 18, 2024, researchers from the National Institutes of Health (NIH) published a proof-of-concept study in Nature Cancer detailing a new artificial intelligence (AI) tool to match patients with the appropriate cancer drug based on their tumor RNA. The tool is called the Personalized Single-Cell Expression-Based for Treatments in Oncology...

Read More


Articles

Mayo Clinic Launches Weight Loss Prescription Program

by

On January 16, 2024, the Mayo Clinic Diet, a weight loss program developed and approved by the Mayo Clinic, announced the beta launch of the Mayo Clinic Diet Medical Weight Loss Rx Program. The growing...

Mississippi Study Indicates COVID Vaccines Reduce Myocarditis Risk

by

At the start of COVID-19 vaccinations, myocarditis rates in Mississippi dropped 14% from pre-vaccination COVID-induced myocarditis rates. The Mississippi-based study was published by a researcher at...

Lilly Announces Mounjaro’s Weight Loss Success in Recent Clinical Trial

by

In an announcement issued earlier this year, Eli Lilly is celebrating the success of Mounjaro in achieving 15.7% weight loss across 72 weeks for obese or overweight adults with type 2 diabetes (T2D)....

Insufficient Sleep Reduces COVID-19 Vaccine Antibody Response

by

Insufficient sleep has detrimental effects on vaccine efficacy. A recent meta-analysis published in Current Biology determined that less than six hours of sleep per night resulted in a reduced antibody...

Long-Acting Injectable Antiretroviral Therapy Suppresses HIV

by

An ongoing study supported by the NIH in San Francisco assessed the efficacy of long-acting antiretroviral therapy (LA-ART), administered via injection, for treating HIV. The study compared LA-ART to...

CDC Analyzes Bivalent mRNA Vaccine Efficacy Against COVID Variants

by

Using data estimates from national pharmacy testing, the CDC analyzed the preliminary efficacy of bivalent mRNA vaccines against multiple COVID variants. The data were collected from December 1, 2022,...

Developing Next-Generation Respiratory Virus Vaccines, Considerations

by

In an article published in Cell Host and Microbe, NIH researchers — including Anthony Fauci, David Morens, and Jeffery Taubenberger — discuss necessary considerations for scientists to...

COVID Vaccines Have Prevented 3,255,656 Deaths

by

COVID vaccines and vaccination campaigns have had unparalleled benefits throughout the COVID-19 pandemic. Many argue that vaccines have been the most effective public health tool against infection....

Developing Next-Generation COVID Vaccines, an Urgent Need

by

As the COVID pandemic has progressed, the healthcare industry has seen the virus and the state of the pandemic evolve. Equipped with the available vaccines and treatments, providers and other...

Understanding the Correlation Between COVID-19 and Flu Vaccination

by

While less than ideal, the progression of the COVID-19 pandemic has presented public health officials with data to analyze on vaccine uptake. In a recent research letter published in JAMA Network Open,...

Digital Health Tools Are Perceived as an Advantage to 93% of Physicians

by

Between 2016 and 2022, the AMA surveyed approximately 1,300 providers in the United States for AMA Digital Health Research. This data collected information on motivations and requirements for digital...

Thermo Fisher Launches Enzyme Analyzers for Assay Applications

by

Thermo Fisher Scientific recently launched single, fully-automated enzyme analyzers designed specifically for enzyme assay applications. The Thermo Scientific Gallery Enzyme Master and Thermo...

Thermo Fisher Launches Portfolio to Advance Quantitative Analysis

by

Thermo Fisher Scientific recently launched a new mass spectrometry (MS) portfolio to advance quantitative analysis.  The Thermo Scientific TSQ Plus triple quadrupole MS portfolio increases...

Pharmaceutical Supply Chain Cybersecurity Risk Tops $31M Annually

by

Ransomware susceptibility for pharmaceutical manufacture supply chain tops $31 million annually, according to new research from Black Kite. Black Kite’s 2021 Ransomware Risk Pulse:...

Abbott Launches Artificial Intelligence-Powered Imaging Platform

by

Abbott recently announced that its artificial intelligence-powered,coronary imaging platform launched in Europe.  The platform, which is now CE marked in Europe, is the first-of-its-kind imaging...

CRISPR Technology Detects COVID-19 From Respiratory RNA Extracts

by

The lack of rapid and accurate molecular diagnostic testing has impeded the healthcare system’s response to the COVID-19 pandemic. Recently, researchers developed rapid, easy-to-implement, and...

GSK, Vir Use CRISPR, Artificial Intelligence to Find COVID-19 Cure

by

GlaxoSmithKline (GSK) and Vir Biotechnology recently announced a collaboration to enhance COVID-19 drug discovery through the use of CRISPR and artificial intelligence. For more coronavirus updates,...

FDA Approves Prescription Digital Therapeutic for Chronic Insomnia

by

Pear Therapeutics recently announced that FDA granted authorization for Somryst, the first prescription digital therapeutic (PDT) to treat adult patients with chronic insomnia. Somryst is a nine-week...

Graphics Processing Units Tech to Accelerate COVID-19 Sequencing

by

Genome-sequencing software NVIDIA announced that it will provide a free 90-day license to Parabricks to any researcher worldwide for rapid  COVID-19 sequencing, according to a recent press...

Recent Articles